Dynavax Technologies Corporation

NasdaqGS DVAX

Dynavax Technologies Corporation Price to Earnings Ratio (P/E) on January 14, 2025: 80.11

Dynavax Technologies Corporation Price to Earnings Ratio (P/E) is 80.11 on January 14, 2025, a 127.83% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Dynavax Technologies Corporation 52-week high Price to Earnings Ratio (P/E) is 176.93 on April 01, 2024, which is 120.84% above the current Price to Earnings Ratio (P/E).
Dynavax Technologies Corporation 52-week low Price to Earnings Ratio (P/E) is -289.48 on January 23, 2024, which is -461.34% below the current Price to Earnings Ratio (P/E).
Dynavax Technologies Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is 31.02.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqGS: DVAX

Dynavax Technologies Corporation

CEO	Mr. Ryan Spencer
IPO Date	Feb. 19, 2004
Location	United States
Headquarters	2100 Powell Street
Employees	408
Sector	Health Care
Industries Vaccines Biotechnology Pharmaceuticals

Description

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Key trends

Past 5 years